Argenx
ARGX
#454
Rank
โ‚น5.265 T
Marketcap
โ‚น84,172
Share price
3.37%
Change (1 day)
72.19%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,521. In 2025 the company made an earnings per share (EPS) of โ‚น2,028 an increase over its 2024 EPS that were of โ‚น1,339.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415-30.24%
2025โ‚น2,02851.44%
2024โ‚น1,339-369.77%
2023-โ‚น496.52-60.46%
2022-โ‚น1,25663.33%
2021-โ‚น768.84-40.37%
2020-โ‚น1,289183.47%
2019-โ‚น454.87123.09%
2018-โ‚น203.9054.93%
2017-โ‚น131.6014.07%
2016-โ‚น115.3713.05%
2015-โ‚น102.05-36.34%
2014-โ‚น160.30209.04%
2013-โ‚น51.87-33.99%
2012-โ‚น78.58185.59%
2011-โ‚น27.52